Drug- Tobacco Interactions
| 
 S.no | 
Product | 
Interactions (TOBACCO) | 
| 
1.         | 
ALPRAZOLAM | 
Concurrent use of ALPRAZOLAM and TOBACCO may
  result in decreased alprazolam plasma concentrations and efficacy | 
| 
2.         | 
CONTRACEPTIVES , COMBINATION | 
Concurrent use of CONTRACCEPTIVES, COMBINATION and
  TOBACCO may result in an increased risk of cardiovascular disease. | 
| 
3.         | 
ERLOTINIB | 
Concurrent use of ERLOTINIB and TOBACCO may
  result in increased erlotinib clearance and reduced serum concentrations. | 
| 
4.         | 
FLUVOXAMINE | 
Concurrent use of 
  FLUVOXAMINE and TOBACCO may result in increased fluvoxamine metabolism | 
| 
5.         | 
IMIPRAMINE  | 
Concurrent use of IMIPRAMINE  and TOBACCO may result in decreased
  imipramine concentrations | 
| 
6.         | 
PENTAZOCINE | 
Concurrent use of PENTAZOCINE  and TOBACCO may result in decreased
  Pentazocine  concentrations | 
| 
7.         | 
PROPOXYPHENE | 
Concurrent use of PROPOXYPHENE and TOBACCO
  may result in decreased Propoxyphene 
  concentrations | 
| 
8.         | 
ROPINIROLE | 
Concurrent use of ROPINIROLE  and TOBACCO may result in decreased
  Ropinirole plasma concentrations and efficacy | 
| 
9.         | 
THEOPHYLLINE | 
Concurrent use of THEOPHYLLINE and TOBACCO
  may result in decreased Theophylline concentrations | 
| 
10.     | 
TOLBUTAMIDE | 
Concurrent use of TOLBUTAMIDE and TOBACCO may result
  in decreased tolbutamide concentrations | 
| 
11.     | 
WARFARIN | 
Concurrent use of  WARFARIN and TOBACCO may result in
  increased or decreased prothrombin time | 
 

 
No comments:
Post a Comment